ZLAB•Zai Lab’s third-quarter net loss widened 28% year over year to $46.14 million, while revenue fell 7% to $108.21 million. A private placement raised about $241.2 million in net proceeds.
Zai Lab’s third-quarter 2026 net loss widened 28% year over year to $46.14 million, primarily due to inventory write-downs, while total revenue fell 7% to $108.21 million. A private placement closed October 27, raising approximately $241.2 million in net proceeds for pipeline development and general corporate purposes. Zoci could support a first U.S. BLA submission in 2027, and management expects the China business to return to growth that year.
